Find the Perfect Plan for Your Investment Journey
B
Latest price
52 Week Range
R$6.84 - R$21.20
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | R$1.23B |
EV | R$1.23B |
Shares Outstanding | 126.84M |
Beta | 0.67 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 10.10% |
EPS | 18.80% |
Operating Cash Flow | 0.70% |
Free Cash Flow | -4.10% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -40.05% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
Biomm S.A.
BIOM3
Sector
Healthcare
Industry
Biotechnology
CEO
Marchezini, Heraldo
Employees
130
Website
www.biomm.comIPO Date
2000-01-11
Headquarters
705 – Lagoa dos Ingleses, Avenida Regent, Alphaville, Nova Lima, Minas Gerais, 34018-000, Brazil
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved